Use of Continuous Renal Replacement Therapy for Removal of Dabigatran in a Patient in Need of Emergent Surgery
Purpose. To report the ability to remove serum dabigatran using continuous renal replacement therapy (CRRT) in a patient with life-threatening bleeding. Summary. A 77-year-old female with history of atrial fibrillation who takes dabigatran for stroke prevention presented with abdominal pain. Patient...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2016-01-01
|
| Series: | Case Reports in Critical Care |
| Online Access: | http://dx.doi.org/10.1155/2016/9692568 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849404907621187584 |
|---|---|
| author | Sara E. Parli Melissa L. Thompson Bastin Daniel A. Lewis |
| author_facet | Sara E. Parli Melissa L. Thompson Bastin Daniel A. Lewis |
| author_sort | Sara E. Parli |
| collection | DOAJ |
| description | Purpose. To report the ability to remove serum dabigatran using continuous renal replacement therapy (CRRT) in a patient with life-threatening bleeding. Summary. A 77-year-old female with history of atrial fibrillation who takes dabigatran for stroke prevention presented with abdominal pain. Patient was found to have bleeding and possible mesenteric ischemia and was taken to the operating room and had continued bleeding postoperatively. CRRT was initiated for the removal of any remaining dabigatran, with serum dabigatran levels collected to evaluate removal of dabigatran with CRRT. This patient had an increased dabigatran level prior to intervention, which decreased to an undetectable level after use of CRRT. Greater than 80% of the drug was removed due to 4 hours of CRRT and residual kidney function. Reversal of dabigatran is an area of current research with recent FDA approval of idarucizumab for use. Conclusion. Bleeding may occur as a result of the use of dabigatran and change in patient’s clinical condition. Use of CRRT may be an option in removing serum dabigatran in the case of a life-threatening bleed. |
| format | Article |
| id | doaj-art-49854f6705b24615976ac8f06951bdac |
| institution | Kabale University |
| issn | 2090-6420 2090-6439 |
| language | English |
| publishDate | 2016-01-01 |
| publisher | Wiley |
| record_format | Article |
| series | Case Reports in Critical Care |
| spelling | doaj-art-49854f6705b24615976ac8f06951bdac2025-08-20T03:36:48ZengWileyCase Reports in Critical Care2090-64202090-64392016-01-01201610.1155/2016/96925689692568Use of Continuous Renal Replacement Therapy for Removal of Dabigatran in a Patient in Need of Emergent SurgerySara E. Parli0Melissa L. Thompson Bastin1Daniel A. Lewis2Department of Pharmacy Services, University of Kentucky HealthCare, Lexington, KY 40536, USADepartment of Pharmacy Services, University of Kentucky HealthCare, Lexington, KY 40536, USADepartment of Pharmacy Services, South Pointe Hospital, Cleveland Clinic, Cleveland, OH 44195, USAPurpose. To report the ability to remove serum dabigatran using continuous renal replacement therapy (CRRT) in a patient with life-threatening bleeding. Summary. A 77-year-old female with history of atrial fibrillation who takes dabigatran for stroke prevention presented with abdominal pain. Patient was found to have bleeding and possible mesenteric ischemia and was taken to the operating room and had continued bleeding postoperatively. CRRT was initiated for the removal of any remaining dabigatran, with serum dabigatran levels collected to evaluate removal of dabigatran with CRRT. This patient had an increased dabigatran level prior to intervention, which decreased to an undetectable level after use of CRRT. Greater than 80% of the drug was removed due to 4 hours of CRRT and residual kidney function. Reversal of dabigatran is an area of current research with recent FDA approval of idarucizumab for use. Conclusion. Bleeding may occur as a result of the use of dabigatran and change in patient’s clinical condition. Use of CRRT may be an option in removing serum dabigatran in the case of a life-threatening bleed.http://dx.doi.org/10.1155/2016/9692568 |
| spellingShingle | Sara E. Parli Melissa L. Thompson Bastin Daniel A. Lewis Use of Continuous Renal Replacement Therapy for Removal of Dabigatran in a Patient in Need of Emergent Surgery Case Reports in Critical Care |
| title | Use of Continuous Renal Replacement Therapy for Removal of Dabigatran in a Patient in Need of Emergent Surgery |
| title_full | Use of Continuous Renal Replacement Therapy for Removal of Dabigatran in a Patient in Need of Emergent Surgery |
| title_fullStr | Use of Continuous Renal Replacement Therapy for Removal of Dabigatran in a Patient in Need of Emergent Surgery |
| title_full_unstemmed | Use of Continuous Renal Replacement Therapy for Removal of Dabigatran in a Patient in Need of Emergent Surgery |
| title_short | Use of Continuous Renal Replacement Therapy for Removal of Dabigatran in a Patient in Need of Emergent Surgery |
| title_sort | use of continuous renal replacement therapy for removal of dabigatran in a patient in need of emergent surgery |
| url | http://dx.doi.org/10.1155/2016/9692568 |
| work_keys_str_mv | AT saraeparli useofcontinuousrenalreplacementtherapyforremovalofdabigatraninapatientinneedofemergentsurgery AT melissalthompsonbastin useofcontinuousrenalreplacementtherapyforremovalofdabigatraninapatientinneedofemergentsurgery AT danielalewis useofcontinuousrenalreplacementtherapyforremovalofdabigatraninapatientinneedofemergentsurgery |